Clinical trial
Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation
NCT05190679 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 27, 2022
- Completion date
- March 3, 2026
- Enrollment
- 155 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.